JPS4849910A - - Google Patents

Info

Publication number
JPS4849910A
JPS4849910A JP47104902A JP10490272A JPS4849910A JP S4849910 A JPS4849910 A JP S4849910A JP 47104902 A JP47104902 A JP 47104902A JP 10490272 A JP10490272 A JP 10490272A JP S4849910 A JPS4849910 A JP S4849910A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP47104902A
Other languages
Japanese (ja)
Other versions
JPS57843B2 (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS4849910A publication Critical patent/JPS4849910A/ja
Publication of JPS57843B2 publication Critical patent/JPS57843B2/ja
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/10Oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06Anabolic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • C07D233/38One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
JP10490272A 1971-10-23 1972-10-21 Expired JPS57843B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2152967A DE2152967C3 (en) 1971-10-23 1971-10-23 Acylureidopenicillins

Publications (2)

Publication Number Publication Date
JPS4849910A true JPS4849910A (en) 1973-07-14
JPS57843B2 JPS57843B2 (en) 1982-01-08

Family

ID=5823251

Family Applications (2)

Application Number Title Priority Date Filing Date
JP10490172A Expired JPS55391B2 (en) 1971-10-23 1972-10-21
JP10490272A Expired JPS57843B2 (en) 1971-10-23 1972-10-21

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP10490172A Expired JPS55391B2 (en) 1971-10-23 1972-10-21

Country Status (31)

Country Link
JP (2) JPS55391B2 (en)
AR (1) AR195805A1 (en)
AT (1) AT320152B (en)
BE (1) BE790440A (en)
BG (2) BG21609A3 (en)
CA (1) CA1019323A (en)
CH (1) CH579089A5 (en)
CS (1) CS188883B2 (en)
CY (1) CY947A (en)
DD (1) DD106044B3 (en)
DE (1) DE2152967C3 (en)
DK (1) DK134992C (en)
EG (1) EG10826A (en)
ES (1) ES407851A1 (en)
FI (1) FI56839C (en)
FR (1) FR2157908B1 (en)
GB (1) GB1392849A (en)
HK (1) HK18578A (en)
HU (1) HU167986B (en)
IE (1) IE37123B1 (en)
IL (1) IL40628A (en)
KE (1) KE2824A (en)
LU (1) LU66332A1 (en)
NO (1) NO143909C (en)
PH (1) PH9893A (en)
PL (2) PL89056B1 (en)
RO (2) RO63066A (en)
SE (1) SE412236B (en)
SU (1) SU527139A3 (en)
YU (1) YU264072A (en)
ZA (1) ZA727473B (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3978056A (en) * 1971-10-23 1976-08-31 Bayer Aktiengesellschaft Penicillins
US3972869A (en) * 1971-10-23 1976-08-03 Bayer Aktiengesellschaft Penicillins
US3983105A (en) * 1971-10-23 1976-09-28 Bayer Aktiengesellschaft Penicillins
US3972870A (en) * 1971-10-23 1976-08-03 Bayer Aktiengesellschaft Penicillins
NL175419C (en) * 1971-10-23 1984-11-01 Bayer Ag METHOD FOR PREPARING OR MANUFACTURING ANTIBIOTIC ACTIVE PHARMACEUTICAL PREPARATIONS AND METHOD FOR PREPARING ANTIBIOTIC ACTIVE ALPHA-SUBSTITUTED 6- (ALFA- (3-ACYLUREIDO) -PETYL-ACIDYL-ACIDYL-ACIDYL)
US3974141A (en) * 1971-10-23 1976-08-10 Bayer Aktiengesellschaft Penicillins
US3974142A (en) * 1971-10-23 1976-08-10 Bayer Aktiengesellschaft Penicillins
US4009272A (en) * 1971-10-23 1977-02-22 Bayer Aktiengesellschaft Penicillins
DE2258973A1 (en) * 1972-12-01 1974-06-06 Bayer Ag PENICILLIN, THE METHOD FOR MANUFACTURING IT AND THEIR USE AS A MEDICINAL PRODUCT
JPS587637B2 (en) * 1973-12-27 1983-02-10 住友化学工業株式会社 Shinkipenicillin no Seihou
DE2407715C2 (en) * 1974-02-18 1982-12-02 Bayer Ag, 5090 Leverkusen Cephalosporins, processes for their production, as well as pharmaceuticals
IL47168A (en) * 1974-05-09 1979-07-25 Toyama Chemical Co Ltd Mono or dioxo piperazino(thio)carbonylamino derivatives ofpenicillins and cephalosporins and process for producing the same
DE2525541C2 (en) * 1975-06-07 1984-01-12 Bayer Ag, 5090 Leverkusen β-lactam antibiotics, processes for their preparation and pharmaceuticals containing them
DE2810083A1 (en) 1978-03-08 1979-09-20 Bayer Ag BETA-LACTAM COMPOUNDS
GB0420722D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
EP1780213A1 (en) * 2005-10-27 2007-05-02 3M Innovative Properties Company Silicon-urea-azolides, their preparation and use in the preparation of silicones with isocyanate terminal groups
TWI417095B (en) 2006-03-15 2013-12-01 Janssen Pharmaceuticals Inc 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mglur2-receptors
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
CN101801951B (en) 2007-09-14 2013-11-13 杨森制药有限公司 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-[1, 4'] bipyridinyl-2'-ones
AU2008297877C1 (en) 2007-09-14 2013-11-07 Addex Pharma S.A. 1,3-disubstituted-4-phenyl-1 H-pyridin-2-ones
EP2200985B1 (en) 2007-09-14 2011-07-13 Ortho-McNeil-Janssen Pharmaceuticals, Inc. 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
CN101861316B (en) 2007-11-14 2013-08-21 奥梅-杨森制药有限公司 Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
ES2439291T3 (en) 2008-09-02 2014-01-22 Janssen Pharmaceuticals, Inc. 3-Azabicyclo [3.1.0] hexyl derivatives as modulators of metabotropic glutamate receptors
JP5656848B2 (en) 2008-10-16 2015-01-21 ジャンセン ファーマシューティカルズ, インコーポレイテッド. Indole and benzomorpholine derivatives as metabotropic glutamate receptor modulators
US8691813B2 (en) 2008-11-28 2014-04-08 Janssen Pharmaceuticals, Inc. Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
MX2011011962A (en) 2009-05-12 2012-02-28 Janssen Pharmaceuticals Inc 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors.
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
ME01573B (en) 2009-05-12 2014-09-20 Addex Pharma Sa 1,2,4-triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
RU2016115906A (en) * 2009-06-10 2018-11-28 Текфилдз Байокем Ко., Лтд. COMPOSITIONS OR MEDICATIONS OF ANTIMO-MICROBIAL AND RELATIVE ANTIMO-MICROBIAL COMPOUNDS Possessing a High Penetrating Ability
US9271967B2 (en) 2010-11-08 2016-03-01 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
JP5852666B2 (en) 2010-11-08 2016-02-03 ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド 1,2,4-Triazolo [4,3-a] pyridine derivatives and their use as positive allosteric modulators of the mGluR2 receptor
AU2011328195B2 (en) 2010-11-08 2015-04-02 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
JO3368B1 (en) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
JO3367B1 (en) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv 1,2,4-TRIAZOLO[4,3-a]PYRIDINE COMPOUNDS AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
PL3096790T3 (en) 2014-01-21 2020-01-31 Janssen Pharmaceutica, N.V. Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
KR20200036063A (en) 2014-01-21 2020-04-06 얀센 파마슈티카 엔.브이. Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1770620A1 (en) * 1968-06-12 1971-11-11 Bayer Ag New penicillins

Also Published As

Publication number Publication date
DE2152967B2 (en) 1981-02-19
DD106044B3 (en) 1990-07-18
YU264072A (en) 1982-06-18
HK18578A (en) 1978-04-14
FI56839C (en) 1980-04-10
DE2152967A1 (en) 1973-05-03
JPS55391B2 (en) 1980-01-08
SU527139A3 (en) 1976-08-30
BE790440A (en) 1973-04-24
FR2157908A1 (en) 1973-06-08
IE37123L (en) 1973-04-23
GB1392849A (en) 1975-04-30
CS188883B2 (en) 1979-03-30
IE37123B1 (en) 1977-05-11
EG10826A (en) 1976-12-31
DD106044A5 (en) 1974-05-20
KE2824A (en) 1978-04-07
PH9893A (en) 1976-06-08
NO143909C (en) 1981-05-06
IL40628A0 (en) 1972-12-29
DE2152967C3 (en) 1981-11-19
ZA727473B (en) 1973-07-25
CA1019323A (en) 1977-10-18
RO60670A (en) 1976-10-15
IL40628A (en) 1976-08-31
FR2157908B1 (en) 1976-03-19
FI56839B (en) 1979-12-31
HU167986B (en) 1976-02-28
BG20813A3 (en) 1975-12-20
CH579089A5 (en) 1976-08-31
AR195805A1 (en) 1973-11-09
SE412236B (en) 1980-02-25
NO143909B (en) 1981-01-26
DK134992C (en) 1977-07-18
PL89056B1 (en) 1976-10-30
BG21609A3 (en) 1976-07-20
LU66332A1 (en) 1973-01-23
AU4806472A (en) 1974-04-26
DK134992B (en) 1977-02-21
ES407851A1 (en) 1975-10-01
RO63066A (en) 1978-06-15
PL93574B1 (en) 1977-06-30
CY947A (en) 1978-06-23
JPS57843B2 (en) 1982-01-08
JPS4849787A (en) 1973-07-13
AT320152B (en) 1975-01-27

Similar Documents

Publication Publication Date Title
FR2157908B1 (en)
AU2658571A (en)
AU2691671A (en)
AU3005371A (en)
AU2742671A (en)
AU2564071A (en)
AU2684071A (en)
AU2669471A (en)
AU2836771A (en)
AU2854371A (en)
AU2684171A (en)
AU3038671A (en)
AU2724971A (en)
AU2503871A (en)
AU2726271A (en)
AU2740271A (en)
AU2837671A (en)
AU2963771A (en)
AU2577671A (en)
AU2588771A (en)
AU2654071A (en)
AU2706571A (en)
AU2755871A (en)
BG26673A3 (en)
CH545813A (en)